Literature Reviews

doi: 10.25005/2074-0581-2020-22-4-629-634
COMPLICATIONS OF AUGMENTATION MAMMOPLASTY

I.V. Sergeev, T.R. Fayzullin, D.P. Larionov

Moscow Regional Research Clinical Institute named after M.F. Vladimirsky, Moscow, Russian Federation

Augmentation mammoplasty is one of the most demanded and most frequently performed plastic surgeries in the world. The first breast augmentation using first-generation implants performed in 1962. Since, the surgery technique and the quality of implants have been improved. Although the number of complications significantly decreased, they still occur both in the early and the late postoperative periods. Often complications include seroma, hematoma, asymmetry, double bubble (double fold), implant displacement, rippling, capsular contracture, etc. The most formidable late complication described in 1997, is breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), which is manifested more than after a year, by the formation of the late malignant seroma after implantation. A review of modern literature provides a clear idea of the number of received complications. However, the pathogenesis of the development of some of them (capsular contracture, implant-associated lymphoma) is still unclear, and therefore, further long-term studies are needed to obtain more accurate data.

Keywords: Augmentation mammoplasty, double fold (double bubble), capsular contracture, seroma, hematoma, implant-associated lymphoma.

Download file:


References
  1. Gabka KD, Bomert H. Plasticheskaya i rekonstruktivnaya khirurgiya molochnoy zhelezy. Per. s angl. [Plastic and reconstructive breast surgery]. Moscow, RF: MEDpress-inform; 2010. 359 p.
  2. Pinchuk V.D. Prichiny i osobennosti vypolneniya otdalyonnykh povtornykh operatsiy posle uvelichivayushchey mammoplastiki [Reasons and features of performing long-term reoperations after augmentation mammoplasty]. Annaly plasticheskoy, rekonstruktivnoy i esteticheskoy khirurgii. 2010;1:39-44.
  3. ASPS National Clearinghouse of Plastic Surgery Procedural Statistics. Available from: https://www.plasticsurgery.org/documents/News/Statistics/2019/ plastic-surgery-statistics-full-report-2019.pdf.
  4. Nahabedian MY, Patel K. Management of common and uncommon problems after primary breast augmentation. Clin Plast Surg. 2009;36(1):127-38. Available from: https://doi.org/10.1016/j.cps.2008.07.002
  5. Clemens MW, Horwitz SM. NCCN Consensus Guidelines for the diagnosis and management of breast implant-associated anaplastic large cell lymphoma. Aesthet Surg J. 2017;37(3):285-9. Available from: https://doi.org/10.1093/ asj/sjw259
  6. Aladily TN, Nathwani BN, Miranda RN, Kansal R, Yin CC, Protzel R, et al. Extranodal NK/T-cell lymphoma, nasal type, arising in association with saline breast implant: expanding the spectrum of breast implant-associated lymphomas. Am J Surg Pathol. 2012;36(11):1729-34. Available from: https://doi. org/10.1097/PAS.0b013e31826a006f
  7. Keech JA Jr, Creech BJ. Anaplastic T-cell lymphoma in proximity to a saline- filled breast implant. Plast Reconstr Surg. 1997;100(2):554-5. Available from: https://doi.org/10.1097/00006534-199708000-00065
  8. Loch-Wilkinson A, Beath KJ, Knight RJW, Wessels WLF, Magnusson M, Papadopoulos T, et al. Breast implant-associated anaplastic large cell lymphoma in Australia and New Zealand: High-surface-area textured implants are associated with increased risk. Plast Reconstr Surg. 2017;140(4):645-54. Available from: https://doi.org/10.1097/PRS.0000000000003654
  9. Rastogi P, Deva AK, Prince HM. Breast implant-associated anaplastic large cell lymphoma. Curr Hematol Malig Rep. 2018;13(6):516-24. Available from: https://doi.org/10.1007/s11899-018-0478-2
  10. Wolfram D, Rabensteiner E, Grundtman C, Böck G, Mayerl C, Parson W, et al. T regulatory cells and TH17 cells in peri-silicone implant capsular fibrosis. Plast Reconstr Surg. 2012;129(2):327e-337e. Available from: https://doi. org/10.1097/PRS.0b013e31823aeacf
  11. Fleury EF, Rêgo MM, Ramalho LC, Ayres VJ, Seleti RO, Ferreira CA, et al. Silicone- induced granuloma of breast implant capsule (SIGBIC): similarities and differences with anaplastic large cell lymphoma (ALCL) and their differential diagnosis. Breast Cancer. 2017;9:133-40. Available from: https://doi. org/10.2147/BCTT.S126003
  12. Mazzocchi M, Dessy LA, Corrias F, Scuderi N. A clinical study of late seroma in breast implantation surgery. Aesthet Plast Surg. 2012;36(1):97-104. Available from: https://doi.org/10.1007/s00266-011-9755-3
  13. Ravi-Kumar S, Sanaei O, Vasef M, Rabinowitz I, Fekrazad MH. Anaplastic large cell lymphoma associated with breast implants. World J Plast Surg. 2012;1(1):30-5.
  14. Cappellano G, Ploner C, Lobenwein S, Sopper S, Hoertnagl P, Mayerl C, et al. Immunophenotypic characterization of human T cells after in vitro exposure to different silicone breast implant surfaces. PLoS One. 2018;13(2):e0192108. Available from: https://doi.org/10.1371/journal. pone.0192108
  15. Ajdic D, Zoghbi Y, Gerth D, Panthaki ZJ, Thaller S. The relationship of bacterial biofilms and capsular contracture in breast implants. Aesthet Surg J. 2016;36(3):297-309. Available from: https://doi.org/ 10.1093/asj/sjv177
  16. Hu H, Jacombs A, Vickery K, Merten SL, Pennington DG, Deva AK. Chronic biofilm infection in breast implants is associated with an increased T-cell lymphocytic infiltrate: implications for breast implant-associated lymphoma. Plast Reconstr Surg. 2015;135(2):319-29. Available from: https://doi. org/10.1097/PRS.0000000000000886
  17. Myint AA, Lee W, Mun S, Ahn CH, Lee S, Yoon J. Influence of membrane surface properties on the behavior of initial bacterial adhesion and biofilm development onto nanofiltration membranes. Biofouling. 2010;26(3):313-21. Available from: https://doi.org/10.1080/08927010903576389
  18. Jacombs A, Tahir S, Hu H, Deva AK, Almatroudi A, Wessels WL, et al. In vitro and in vivo investigation of the influence of implant surface on the formation of bacterial biofilm in mammary implants. Plast Reconstr Surg. 2014;133(4):471e-80e. Available from: https://doi.org/10.1097/ PRS.0000000000000020
  19. Brody GS, Deapen D, Taylor CR, Pinter-Brown L, House-Lightner SR, Andersen JS, et al. Anaplastic large cell lymphoma occurring in women with breast implants: analysis of 173 cases. Plast Reconstr Surg. 2015;135(3):695-705. Available from: https://doi.org/10.1097/PRS.0000000000001033
  20. Doren EL, Miranda RN, Selber JC, Garvey PB, Liu J, Medeiros LJ, et al. U.S. epidemiology of breast implant-associated anaplastic large cell lymphoma. Plast Reconstr Surg. 2017;139(5):1042-50. Available from: https://doi. org/10.1097/PRS.0000000000003282
  21. McGuire P, Reisman NR, Murphy DK. Risk factor analysis for capsular contracture, malposition, and late seroma in subjects receiving Natrelle 410 form-stable silicone breast implants. Plast Reconstr Surg. 2017;139(1):1-9. Available from: https://doi.org/10.1097/PRS.0000000000002837
  22. Elswick SM, Nguyen MT. Breast erythema in a patient with breast implant-associated anaplastic large cell lymphoma: A case report discussing cutaneous manifestations. Aesthet Surg J. 2018;38(3):NP47-NP52. Available from: https://doi.org/10.1093/asj/sjx209
  23. Cheson BD, Fisher RI, Barrington SF. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32(27):3059-68. Available from: https://doi.org/10.1200/JCO.2013.54.8800
  24. Santanelli di Pompeo F, Laporta R, Sorotos M, Di Napoli A, Giovagnoli MR, Cox MC, et al. Breast implant-associated anaplastic large cell lymphoma: Proposal for a monitoring protocol. Plast Reconstr Surg. 2015;136(2):144e-151e. Available from: https://doi.org/10.1097/PRS.0000000000001416
  25. Clemens MW, Jacobsen ED, Horwitz SM. 2019 NCCN Consensus Guidelines on the diagnosis and treatment of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Aesthet Surg J. 2019;39(Suppl_1):S3-S13. Available from: https://doi.org/10.1093/asj/sjy331
  26. Malahias M, Jordan D, Hughes L, Hindocha S, Juma A. A literature review and summary of capsular contracture: An ongoing challenge to breast surgeons and their patients. International Journal of Surgery Open. 2016;3:1-7. Available from: https://doi.org/10.1016/j.ijso.2016.04.001
  27. Headon H, Kasem A, Mokbel K. Capsular contracture after breast augmentation: An update for clinical practice. Archives of Plastic Surgery. 2015;42(5):532. Available from: https://doi.org/10.5999/aps.2015.42.5.532
  28. Khodzhamuradov GM, Saidov MS, Ismoilov MM. Augmentatsionnaya mammoplastika s primeneniyem silikonovykh implantatov bol’shikh razmerov [Augmentation mammoplasty with large silicone implants]. Vestnik Avitsenny [Avicenna Bulletin]. 2016;2:60-3.
  29. Egorov VA, Savelyev EI, Strygin AV. Luchevaya diagnostika oslozhneniy augmentatsionnoy mammoplastiki [Radiation diagnosis of complications of augmentation mammoplasty]. Annaly plasticheskoy, rekonstruktivnoy i esteticheskoy khirurgii. 2012;4:45-50
  30. Smith TL, Sautter NB. Is montelukast indicated for treatment of chronic rhinosinusitis with polyposis? Laryngoscope. 2014;124(8):1735-6. Available from: https://doi.org/10.1002/lary.24477
  31. Collins JB, Verheyden CN. Incidence of breast hematoma after placement of breast prostheses. Plast Reconstr Surg. 2012;129(3):413e-420e. Available from: https://doi.org/10.1097/PRS.0b013e3182402ce0
  32. Stojkovic CA, Smeulders MJ, Van der Horst CM, Khan SM. Wound drainage after plastic and reconstructive surgery of the breast. Cochrane Database Syst Rev. 2013;(3):CD007258. Available from: https://doi.org/10.1002/14651858. CD007258.pub2
  33. Sbitany H, Serletti JM. Acellular dermis-assisted prosthetic breast reconstruction: a systematic and critical review of efficacy and associated morbidity. Plast Reconstr Surg. 2011;128(6):1162-9. Available from: https://doi. org/10.1002/14651858.CD007258
  34. Bengtson B, Brody GS, Brown MH, Glicksman C, Hammond D, Kaplan H, et al. Managing late periprosthetic fluid collections (seroma) in patients with breast implants: a consensus panel recommendation and review of the literature. Plast Reconstr Surg. 2011;128(1):1-7. Available from: https://doi. org/10.1097/PRS.0b013e318217fdb0
  35. Kim B, Roth C, Chung KC, Young VL, van Busum K, Schnyer C, et al. Anaplastic large cell lymphoma and breast implants: a systematic review. Plast Reconstr Surg. 2011;127(6):2141-50. Available from: https://doi.org/10.1097/ PRS.0b013e3182172418
  36. Codner MA, Mejia JD, Locke MB, Mahoney A, Thiels C, Nahai FR, et al. A 15-year experience with primary breast augmentation. Plast Reconstr Surg. 2011;127(3):1300-10. Available from: https://doi.org/10.1097/PRS.0b013e- 318205f41b
  37. Spear SL, Seruya M, Clemens MW, Teitelbaum S, Nahabedian MY. Acellular dermal matrix for the treatment and prevention of implant-associated breast deformities. Plast Surg Nurs. 2017;37(2):76-87. Available from: https://doi. org/10.1097/PSN.0000000000000189
  38. Jung HK, Kim CH, Song SY. Prospective 1-year follow-up study of breast augmentation by cell-assisted lipotransfer. Aesthet Surg J. 2016;36(2):179-90. Available from: https://doi.org/10.1016/j.jpra.2016.08.004
  39. Voglimacci M, Garrido I, Mojallal A, Vaysse C, Bertheuil N, Michot A, et al. Autologous fat grafting for cosmetic breast augmentation: a systematic review. Aesthet Surg J. 2015;35(4):378-93. Available from: https://doi.org/10.1093/ asj/sjv030
  40. Leopardi D, Thavaneswaran P, Mutimer KL, Olbourne NA, Maddern GJ. Autologous fat transfer for breast augmentation: a systematic review. ANZ J Surg. 2014;84(4):225-30. Available from: https://doi.org/10.1111/ans.12202
  41. Li X, Guo X. Progressive fat necrosis after breast augmentation with autologous lipotransfer: a cause of long-lasting high Fever and axillary lymph node enlargement. Aesthetic Plast Surg. 2015;39(3):386-90. Available from: https://doi.org/10.1007/s00266-015-0480-1

Author information:


Sergeev Ilya Vyacheslavovich
Candidate of Medical Sciences, Professor, Course of Plastic Surgery at the Department of Oncology and Thoracic Surgery, Moscow Regional Research Clinical Institute named after M.F. Vladimirsky
ORCID ID: 0000-0002-1865-5457
E-mail: ilyadoc@yandex.ru

Fayzullin Tagir Rishatovich
Candidate of Medical Sciences, Associate Professor, Course of Plastic Surgery at the Department of Oncology and Thoracic Surgery, Moscow Regional Research Clinical Institute named after M.F. Vladimirsky
ORCID ID: 0000-0002-3972-7448
E-mail: tagir@dr-fayzullin.ru

Larionov David Pashavich
Clinical Resident, Course of Plastic Surgery at the Department of Oncology and Thoracic Surgery, Moscow Regional Research Clinical Institute named after M.F. Vladimirsky
ORCID ID: 0000-0002-0020-2521
E-mail: davidpashavich@yandex.ru

Information about support in the form of grants, equipment, medications

The authors did not receive financial support from manufacturers of medicines and medical equipment

Conflicts of interest: No conflict

Address for correspondence:


Larionov David Pashavich
Clinical Resident, Course of Plastic Surgery at the Department of Oncology and Thoracic Surgery, Moscow Regional Research Clinical Institute named after M.F. Vladimirsky

129110, Russian Federation, Moscow, Shchepkina str., 61/2

Tel.: +7 (916) 3084039

E-mail: davidpashavich@yandex.ru